These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21636701)

  • 1. Different gene expression profiles in metastasizing midgut carcinoid tumors.
    Edfeldt K; Björklund P; Åkerström G; Westin G; Hellman P; Stålberg P
    Endocr Relat Cancer; 2011 Aug; 18(4):479-89. PubMed ID: 21636701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.
    Kidd M; Eick G; Shapiro MD; Camp RL; Mane SM; Modlin IM
    Cancer; 2005 Jan; 103(2):229-36. PubMed ID: 15599934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression in midgut carcinoid tumors: potential targets for immunotherapy.
    Vikman S; Essand M; Cunningham JL; de la Torre M; Oberg K; Tötterman TH; Giandomenico V
    Acta Oncol; 2005; 44(1):32-40. PubMed ID: 15848904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets.
    Capurso G; Lattimore S; Crnogorac-Jurcevic T; Panzuto F; Milione M; Bhakta V; Campanini N; Swift SM; Bordi C; Delle Fave G; Lemoine NR
    Endocr Relat Cancer; 2006 Jun; 13(2):541-58. PubMed ID: 16728581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients.
    Feng Y; Sun B; Li X; Zhang L; Niu Y; Xiao C; Ning L; Fang Z; Wang Y; Zhang L; Cheng J; Zhang W; Hao X
    Breast Cancer Res Treat; 2007 Jul; 103(3):319-29. PubMed ID: 17123152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First report on metastasizing small bowel carcinoids in first-degree relatives in three generations.
    Järhult J; Landerholm K; Falkmer S; Nordenskjöld M; Sundler F; Wierup N
    Neuroendocrinology; 2010; 91(4):318-23. PubMed ID: 20460879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of genetic markers--NAP1L1, MAGE-D2, and MTA1--in defining small-intestinal carcinoid neoplasia.
    Kidd M; Modlin IM; Mane SM; Camp RL; Eick G; Latich I
    Ann Surg Oncol; 2006 Feb; 13(2):253-62. PubMed ID: 16424981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors.
    Cunningham JL; Díaz de Ståhl T; Sjöblom T; Westin G; Dumanski JP; Janson ET
    Genes Chromosomes Cancer; 2011 Feb; 50(2):82-94. PubMed ID: 21104784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.
    Hellman P; Lundström T; Ohrvall U; Eriksson B; Skogseid B; Oberg K; Tiensuu Janson E; Akerström G
    World J Surg; 2002 Aug; 26(8):991-7. PubMed ID: 12016480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing key biological pathways between primary breast cancers and their lymph node metastases by gene function-based clustering analysis.
    Lähdesmäki H; Hao X; Sun B; Hu L; Yli-Harja O; Shmulevich I; Zhang W
    Int J Oncol; 2004 Jun; 24(6):1589-96. PubMed ID: 15138604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression.
    Seitz S; Korsching E; Weimer J; Jacobsen A; Arnold N; Meindl A; Arnold W; Gustavus D; Klebig C; Petersen I; Scherneck S
    Genes Chromosomes Cancer; 2006 Jun; 45(6):612-27. PubMed ID: 16552773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
    Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
    Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.
    Chaudhry A; Gobl A; Eriksson B; Skogseid B; Oberg K
    Cancer Res; 1994 Feb; 54(4):981-6. PubMed ID: 7508823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
    Van Eeden S; Quaedvlieg PF; Taal BG; Offerhaus GJ; Lamers CB; Van Velthuysen ML
    Hum Pathol; 2002 Nov; 33(11):1126-32. PubMed ID: 12454818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer metastases are molecularly distinct from their primary tumors.
    Vecchi M; Confalonieri S; Nuciforo P; Viganò MA; Capra M; Bianchi M; Nicosia D; Bianchi F; Galimberti V; Viale G; Palermo G; Riccardi A; Campanini R; Daidone MG; Pierotti MA; Pece S; Di Fiore PP
    Oncogene; 2008 Apr; 27(15):2148-58. PubMed ID: 17952122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
    Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C
    Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis.
    Dutertre M; Lacroix-Triki M; Driouch K; de la Grange P; Gratadou L; Beck S; Millevoi S; Tazi J; Lidereau R; Vagner S; Auboeuf D
    Cancer Res; 2010 Feb; 70(3):896-905. PubMed ID: 20103641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.